Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML.

Bultitude, Will P; Schellekens, Jennifer; Szydlo, Richard M; Anthias, Chloe; Cooley, Sarah A; Miller, Jeffrey S; Weisdorf, Daniel J; Shaw, Bronwen E; Roberts, Chrissy H; Garcia-Sepulveda, Christian A; +17 more... Lee, Julia; Pearce, Rachel M; Wilson, Marie C; Potter, Michael N; Byrne, Jenny L; Russell, Nigel H; MacKinnon, Stephen; Bloor, Adrian J; Patel, Amit; McQuaker, I Grant; Malladi, Ram; Tholouli, Eleni; Orchard, Kim; Potter, Victoria T; Madrigal, J Alejandro; Mayor, Neema P; Marsh, Steven GE; (2020) Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML. Bone Marrow Transplantation. ISSN 0268-3369 DOI: https://doi.org/10.1038/s41409-020-0858-9

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1038/s41409-020-0858-9

Abstract

Item Type Article
Faculty and Department Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
PubMed ID 32203258
Elements ID 145276

Share

Download

Embargo Date: 13 September 2020

Restricted to: Repository staff only

Request a copy

Filename: Original_submission_KIR_genotype_in_UK_HCT.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

[img]

Downloads

View details

Metrics & Citations


Google Scholar